Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Frank Buck who wrote (730)	12/19/1997 1:15:00 PM
From: John Posatiere	Read Replies (2) \| Respond to of 1894

UBS today just downgraded Autocyte as well.

To: Frank Buck who wrote (730)	12/19/1997 1:26:00 PM
From: Sigmund	Read Replies (2) \| Respond to of 1894

Yes there are some postings about the Populist Cytologist and CYTEC's answer (which I haven't looked at) I think on the ACMI thread. I think the jury is still out on the Thin Prep. The case made by the Populist Cytologist was that the benefits may have been overstated. I need to take a look at Cytec's response. Either way I think the FDA will be very careful now. It is a shame that there is this infighting but I guess the stakes are very high.